OrbiMed’s Adaptimmune Therapeutics ADAP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
|
|||||
|
2020
Q1 | $6.87M | Buy |
|
|||||
|
2019
Q4 | $1.62M | Hold |
|
|||||
|
2019
Q3 | $2.04M | Hold |
|
|||||
|
2019
Q2 | $5.43M | Hold |
|
|||||
|
2019
Q1 | $5.81M | Hold |
|
|||||
|
2018
Q4 | $7.77M | Buy |
|
|||||
|
2018
Q3 | $9.04M | Hold |
|
|||||
|
2018
Q2 | $7.91M | Sell |
|
|||||
|
2018
Q1 | $9.73M | Sell |
|
|||||
|
2017
Q4 | $12.8M | Hold |
|
|||||
|
2017
Q3 | $15.7M | Hold |
|
|||||
|
2017
Q2 | $8.6M | Hold |
|
|||||
|
2017
Q1 | $10.6M | Buy |
|
|||||
|
2016
Q4 | $2.93M | Hold |
|
|||||
|
2016
Q3 | $5.11M | Hold |
|
|||||
|
2016
Q2 | $5.9M | Buy |
|
|||||
|
2016
Q1 | $3.57M | Hold |
|
|||||
|
2015
Q4 | $5.29M | Buy |
|
|||||
|
2015
Q3 | $2.11M | Sell |
|
|||||
|
2015
Q2 | $80.9M | Buy |
|